Baricitinib treatment of COVID-19 is associated with a reduction of secondary infections

Daniel A Sweeney; Bonifride Tuyishimire; Neera Ahuja; John H Beigel; Tatiana Beresnev; Valeria D Cantos; Jose G Castro; Stuart H Cohen; Kaitlyn Cross; Lori E Dodd

Baricitinib treatment of COVID-19 is associated with a reduction of secondary infections

Daniel A Sweeney
, Bonifride Tuyishimire
, Neera Ahuja
, John H Beigel
, Tatiana Beresnev
, Valeria D Cantos
, Jose G Castro
, Stuart H Cohen
, Kaitlyn Cross
, Lori E Dodd

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

Original language	English
Title of host publication	Open Forum Infectious Diseases
Pages	ofad205
State	Published - 2023
Externally published	Yes

Cite this

@inproceedings{f5b5483aa5a94bf48e553342faef4bc2,

title = "Baricitinib treatment of COVID-19 is associated with a reduction of secondary infections",

author = "Sweeney, \{Daniel A\} and Bonifride Tuyishimire and Neera Ahuja and Beigel, \{John H\} and Tatiana Beresnev and Cantos, \{Valeria D\} and Castro, \{Jose G\} and Cohen, \{Stuart H\} and Kaitlyn Cross and Dodd, \{Lori E\}",

year = "2023",

language = "English",

pages = "ofad205",

booktitle = "Open Forum Infectious Diseases",

}

TY - GEN

T1 - Baricitinib treatment of COVID-19 is associated with a reduction of secondary infections

AU - Sweeney, Daniel A

AU - Tuyishimire, Bonifride

AU - Ahuja, Neera

AU - Beigel, John H

AU - Beresnev, Tatiana

AU - Cantos, Valeria D

AU - Castro, Jose G

AU - Cohen, Stuart H

AU - Cross, Kaitlyn

AU - Dodd, Lori E

PY - 2023

Y1 - 2023

M3 - Conference contribution

SP - ofad205

BT - Open Forum Infectious Diseases

ER -

Baricitinib treatment of COVID-19 is associated with a reduction of secondary infections

Fingerprint

Cite this